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Macrophages are present in regenerating skeletal muscles and participate in the repair
process.This is due to a unique feature of macrophages, i.e., their ability to perceive signals
heralding ongoing tissue injury and to broadcast the news to cells suited at regenerating
the tissue such as stem and progenitor cells. Macrophages play a complex role in the skele-
tal muscle, probably conveying information on the pattern of healing which is appropriate
to ensure an effective healing of the tissue, yielding novel functional ﬁbers. Conversely,
they are likely to be involved in limiting the efﬁcacy of regeneration, with formation of
ﬁbrotic scars and fat replacement of the tissue when the original insult persists. In this
review we consider the beneﬁcial versus the detrimental actions of macrophages during
the response to muscle injury, with attention to the available information on the molecular
code macrophages rely on to guide, throughout the various phases of muscle healing,
the function of conventional and unconventional stem cells. Decrypting this code would
represent a major step forward toward the establishment of novel targeted therapies for
muscle diseases.
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MUSCLE INJURY AND INFLAMMATION
Resident leukocytes in the healthy skeletal muscle are exceedingly
rare. Thereafter, the skeletal muscle represents a microenviron-
ment in which immunologic reactions depend on the character-
istics of the noxious event and on the nature and the function
of newly recruited immune cells (Wiendl et al., 2005). Mus-
cle inﬂammation is a common physiologic response to exer-
cise and the hallmark of acute and chronic damages such as
strain injury or muscular dystrophies. Muscle inﬂammation has
been felt to run a rather stereotypical course; recent data how-
ever indicate that when persistent triggers cause muscle dam-
age, differences exist in the recruitment of the humoral innate
immunity at the site of tissue injury. For example, activation
of the complement cascade occurs and contributes to the dis-
ease in dysferlin-deﬁcient mice, a model for the muscle wasting
diseases referred to as dysferlinopathies, but not in mdx mice,
a mouse model of Duchenne Muscle Dystrophy (Han et al.,
2010).
The inﬂammation in acutely damaged muscle is character-
ized by a rapid and sequential invasion of leukocyte populations
that persist while muscle repair, regeneration, and growth occur
(Paulsen et al., 2010). Neutrophils represent the ﬁrst leukocyte
population in the damaged tissue. They were found in muscle
early after exercise completion (Fielding et al., 1993) and inﬁl-
trate the tissue for as long as 5 days. Neutrophils release molecules
that may contribute to the muscle membrane lysis that follows
injury (Nguyen et al., 2005). The actual ﬁnal effect of neutrophil
recruitment in damaged skeletal muscle is however not com-
pletely elucidated and recent results suggest that inﬁltration by
neutrophils per se may not be harmful but additional inﬂam-
matory stimuli are required to reveal their detrimental potential
(Dumont et al., 2008). Some such stimulimaybedirectly generated
as a consequence of myoﬁber lysis and ensuing release of endoge-
nous inﬂammatory molecules or may be contributed by other
recruited cells, such as platelets (Maugeri et al., 2009; Manfredi
et al., 2010).
Interestingly, genetic disruption of the chemokine pathway
related to inﬂammatory leukocyte recruitment reveals an appar-
ent balance between the extent and the duration of tissue inﬁl-
tration by leukocytes: absence of CXCL16 not only resulted in
defective homing of macrophages and severely jeopardized tissue
regeneration, but was associated with a persistent and important
inﬁltration of the tissue by neutrophils, with unrestrained inﬂam-
mation and eventual ﬁbrosis (Zhang et al., 2009b). Conversely, a
signiﬁcant increase in macrophage accumulation and cell prolif-
eration was observed in mice in which a transient neutropenia
was induced at early times after injury (Godbout et al., 2010). In
general, macrophages represent the dominant leukocyte popula-
tion in the late phases of the homeostatic response to injury or
in conditions in which the original inﬂammatory noxa persists.
Their ability to perceive environmental cues and orchestrate the
functional activities of other cells populations, such as immune
cells or myogenic precursors (Figure 1),makes them an intriguing
ﬁeld of study in muscle biology.
MACROPHAGES: WHAT’S IN A NAME?
Macrophages were originally identiﬁed as phagocytic cells respon-
sible for pathogen elimination and housekeeping functions in
www.frontiersin.org November 2011 | Volume 2 | Article 62 | 1
Bosurgi et al. Macrophages and skeletal muscle regeneration
FIGURE 1 | Macrophages, recruited to the skeletal muscle after acute
sterile injury, are necessary for effective tissue regeneration.Two
months old C57BL/6 mice were treated i.m. with cardiotoxin (CTX). Mice
were treated or not with clodronate-containing liposomes to deplete
macrophages and sacriﬁced 15 days after CTX injection.Tibialis anterior and
quadriceps muscles were collected. (A) Healthy muscles of untreated
control mice. (B)The muscle of macrophage-competent mice undergoes
effective and almost complete regeneration in 15 days: regenerating
centronucleated ﬁbers are evident throughout the section. (C) In the
absence of macrophages, 15 days after acute sterile injury regenerating
ﬁbers are hardly evident. Degenerated ﬁbers and cell remnants persist.
a wide range of organisms (Metchnikoff, 1905): they were thus
included in the Mononuclear Phagocyte System, a population of
cells, derived from bone marrow progenitors, that differentiate,
enter the blood as monocytes and then the peripheral tissues to
become resident macrophages or antigen presenting cells (Van
Furth and Cohn, 1968).
Monocyte half-life in the blood is of about 1 day. This obser-
vation has fostered the concept that blood monocytes replenish
macrophage or dendritic cell (DC) pools in peripheral tissues
to maintain homeostasis (Ziegler-Heitbrock, 2000). This loop, by
which tissues control the size and distribution of theirmacrophage
populations, becomes evident when acute events, such as injury or
infection occur.
Inﬂammation restricts the growth of invading microbes and
guides, when the pathogen has been eliminated, its healing.
Macrophages in particular represent an active link between innate
and adaptive immunity,by regulatingT lymphocyte activation and
possibly shaping their polarization and function. The pioneering
work on the role of T-cell-dependent protective autoimmunity in
the healing of sterile spinal cord injuries makes this contention
particularly cogent (Schwartz and Ziv, 2008; Shechter et al., 2009).
The role of macrophages is non-redundant. Depletion in the
spleen of marginal zone macrophages, which interact with apop-
totic material entering from the circulation, accelerated autoim-
munity in mice genetically prone to systemic lupus erythematosus
and caused signiﬁcant mortality in wild-type mice repeatedly
exposed to apoptotic cells (Mcgaha et al., 2011). Accumulation
of apoptotic cell material per se triggers acceleration of systemic
lupus erythematosus (Bondanza et al., 2003, 2004; Munoz et al.,
2010). Macrophages recognize tags expressed by apoptotic cells: as
a consequence theyononehanddispose of potentially reservoirs of
autoantigens; on the other hand secrete regulatory cytokines that
contribute to maintain self-tolerance (Manfredi et al., 2009; Elliott
and Ravichandran, 2010). The clearance function of macrophages
is crucial to limit the actual cross-presentation of apoptotic cell
antigens and possibly to modify the cytokine environment in
which the productive T-cell activation take place, thus favoring
the establishment of protective, or at least not directly damaging,
immune responses (Acharya et al., 2010; Elliott and Ravichandran,
2010; Brereton and Blander, 2011; Peng and Elkon, 2011).
Macrophages also support matrix remodeling and neoangio-
genesis and have been implicated in conditions in which neoan-
giogenesis is potentially deleterious, including cancer (Qian and
Pollard,2010) but also non-neoplastic conditions, such as rheuma-
toid arthritis or endometriosis (Barrera et al., 2000; Bacci et al.,
2009; Capobianco et al., 2010, 2011). All-together the data strongly
support the ability of macrophages to perceive ongoing injury of
various tissues, and to activate homeostatic programs that through
the clearance of dying cells, the organization of neovessel gener-
ation, the regulation of the extracellular matrix remodeling and
the activation of appropriate T lymphocyte responses leads to the
effective healing.
Macrophage activation is clearly protective in the case of
intense, short lasting injuries. In contrast, macrophage action sus-
taining regenerative and vascular responses can be deleterious in
conditions such as persisting infectious diseases, chronic tissue
damage, or event more notably tumors, in which the initial stim-
ulus perceived by macrophages persists. Several excellent reviews
have addressed the latter issue (e.g., see Biswas and Mantovani,
2010;Gordon andMartinez, 2010;Mantovani and Sica, 2010;Qian
and Pollard, 2010; Squadrito and De Palma, 2011) and we will not
discuss the issue further in this essay.
Dedicated pattern-recognition receptors (PRRs) are non-
clonally expressed by most innate immune cells (Palm and
Medzhitov, 2009). PRRs allow to indentify molecular structures
shared by ample classes of microbes, referred to as pathogen-
associated molecular patterns (PAMPs; Janeway, 1992). The acti-
vation of PRRs results in cascade of tightly coordinated events,
including: (i) the production of cytokines and chemokines, which
attract and activate leukocytes (Nathan, 2002) (ii) the activation
of an acute phase response, with the production of conserved
soluble PRRs, such as pentraxins (Manfredi et al., 2008) which
tune leukocyte activation and limit their ability to damage the
tissue; (iii) the migration of APC to draining lymph nodes, with
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productive activation of naïve T lymphocytes. The expansion of
antigen-speciﬁc T-cells is a key event in the establishment of an
adaptive immunological response (Bevan, 2011).
Damage-associated molecular pattern (DAMP), an array of
heterogeneous molecules that are released during cell and tis-
sue necrosis, although non-microbial, share the ability to activate
PRRs (Table 1). Ss a consequence DAMPs recognition elicits
inﬂammation and prompts tissue regeneration and acquired T-
cell-dependent immune responses even in the context of sterile
injuries (Bianchi, 2007; Lotze et al., 2007; Rubartelli and Lotze,
2007;Urbonaviciute et al., 2008;Bianchi andManfredi,2009;Man-
fredi and Rovere-Querini, 2010; Maroso et al., 2010; Castiglioni
et al., 2011; Liu et al., 2011b; Zhang et al., 2011). Macrophages
undergo an extensive reprogramming of their functional proper-
ties in response to PAMPs (Nau et al., 2002; Martinon et al., 2010),
but also to signals released directly from damaged tissues (London
et al., 2011) and from lymphocytes (Tiemessen et al., 2007; Wong
et al., 2010; Liu et al., 2011a).
Studies with various probes reveal a phenotype heterogene-
ity in macrophages that possibly reﬂects peculiar features and
function of macrophages sub-populations within the microenvi-
ronment. In response to microenvironmental cues, macrophages
in the tissue become potent effector cells integrated in a T helper
(Th)-1 response, which kill microorganisms and tumor cells and
Table 1 | Inflammatory sterile stimuli and associated diseases
(Manfredi and Rovere-Querini, 2010; Rock et al., 2010, 2011; Zhang
et al., 2010a; Castiglioni et al., 2011).
Molecule Associated inflammatory conditions
Asbestos* Asbestosis: lung inﬂammation and ﬁbrosis.
Mesothelioma and lung cancer
ATP, ADP, adenosine Airway inﬂammation
Calcium
pyrophosphate
Pseudogout: chronic inﬂammatory arthritis
Cholesterol crystal Atherosclerosis: arterial inﬂammation and occlu-
sion
DNA constituents Systemic autoimmunity (SLE)
HMGB1 Sepsis, systemic autoimmunity (SLE), rheumatoid
arthritis
Matrix constituents
(hyaluronate,
heparan sulfate,
ﬁbronectin,
ﬁbrinogen, elastin,
and collagen derived
peptide)
Idiopathic pulmonary ﬁbrosis, COPD, nephritis,
arthritis
Mitochondrial DNA Trauma, systemic inﬂammatory response syn-
drome (SIRS)
Mitochondrial formyl
peptides
Trauma, SIRS
Silica Silicosis: lung Inﬂammation and ﬁbrosis
Uric acid Gout: chronic inﬂammatory arthritis
∗via HMGB1 release? See (Yang et al., 2010).
produce copious amounts of cytokines. Microbial destruction is
mediated at least partially by the production of reactive oxy-
gen species (ROS) and nitric oxide (NO). The amount of NO
produced is instrumental for the ability of macrophages to con-
trol the intracellular parasite L. mexicana (Mylonas et al., 2009). In
humans, classically activated macrophages are important for resis-
tance to mycobacteria and Leishmania major infection (Darrah
et al., 2007). Macrophages may undergo an alternative activa-
tion pathway (referred to as “alternative activation”) that endows
them with the ability to tune inﬂammatory responses and adap-
tive immunity, scavenge debris, and promote angiogenesis, tissue
remodeling, and repair (Mantovani et al., 2004).
Macrophages that inﬁltrate regenerating tissues in general
belong to the second class of healing macrophages (Corna et al.,
2010; Daley et al., 2010; O’brien et al., 2010; Schwartz, 2010;
Brancato and Albina, 2011; Cairo et al., 2011; David and Kro-
ner, 2011; Harel-Adar et al., 2011; Jaeschke, 2011; London et al.,
2011; Wang and Harris, 2011), while unrestrained polarization
toward a classically activated phenotype associates with defective
healing andpersistent inﬂammation (Sindrilaru et al., 2011).Heal-
ing (or alternatively activated) macrophages can be propagated
in vitro by exposure to monocyte precursors to low concentra-
tions of M-CSF in the presence of IL4, IL13, or IL10 (Mantovani
et al., 2004). In contrast exposure to microbial components such
as LPS in the presence of γIFN or to GM-CSF is an effective
stimulus to elicit classically activated, inﬂammatory macrophages
(Figure 2).
The dichotomy between inﬂammatory and tissue healing
macrophages represents a “useful over-simpliﬁcation” (Manto-
vani et al., 2009) of a sophisticated array of functions exerted
by macrophage populations in injured tissues. The plasticity of
macrophages in response to environmental cues has been char-
acterized with particular attention in a model tissue, the skeletal
muscle (Brunelli and Rovere-Querini, 2008; Chazaud et al., 2009;
Tidball and Villalta, 2010).
A CASE FOR MACROPHAGES IN THE SKELETAL MUSCLE
Macrophages have been known for a long time to be associated
with skeletal muscle injury (Robertson et al., 1993; Mclennan,
1996). Moreover they play a critical role in the pathogenesis and
in the natural history of self sustaining muscle diseases, specif-
ically including primary inﬂammatory myopathies (necrotizing
autoimmune myositis, inclusion body myositis and polymyositis)
and genetic diseases of the tissue (Duchenne and Becker muscular
dystrophies; Dalakas, 2002; Villalta et al., 2009). In vivo studies
have unequivocally shown that macrophages actually participate
in the tissue repair process (St Pierre and Tidball, 1994; Mclennan,
1996; Chazaud et al., 2003; Warren et al., 2005; Summan et al.,
2006; Arnold et al., 2007; Tidball and Wehling-Henricks, 2007;
Segawa et al., 2008; Ruffell et al., 2009; Sun et al., 2009; Brigitte
et al., 2010; Dumont and Frenette, 2010; Martinez et al., 2010;
Vezzoli et al., 2010; Lu et al., 2011b). Macrophages, as discussed
above, are professional scavengers of apoptotic cells and debris
and produce a vast array of signals involved in matrix remod-
eling and neovessel formation. Data in various models of skeletal
muscle injury, including hindlimb ischemia, freeze-injury,unload-
ing/reloading sequences, and myotoxic agent injection indicate
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FIGURE 2 | Environment cues control and influence macrophage
polarization. Inﬂammatory macrophage activation is driven by stimulation
with LPS or bacteria, and/or IFN-γ or GM-CSF. These molecules induce iNOS
activity on macrophages and consequent production of RNI. Treatment with
IL4 and/or IL13, IL10 and/or M-CSF supports the activation of tissue healing
macrophages. The cytokine network activates an arginase-dependent
metabolism of arginine. In macrophages, acquisition of a speciﬁc polarization
state determines a differential expression of receptors and secretion of
molecules. LPS, lipopolysaccharide; IFN-γ, interferon-γ; GM-CSF, granulocyte
macrophage-colony stimulating factor; M-CSF, macrophage-colony stimulating
factor; MHCII, major histocompatibility complex class II; GR, galactose
receptor; CD163, haptoglobin–hemoglobin complex receptor; CD206,
mannose receptor; TfR1, transferrin receptor 1; Fpn, ferroportin; TGF-β,
transforming growth factor β; IGF1, insulin like growth factor 1; PTX-3,
pentraxin 3; PGE2, prostaglandin E2; MMP-9, matrix metalloproteinase 9;
Fizz, resistin like molecule; Ym1/2, chitinase like protein 1/2; TNF-α, tumor
necrosis factor α; IFN, interferon type I; RNI, reactive nitrogen intermediate;
ROI, reactive oxygen intermediate.
that the recruitment of macrophages in the tissue occurs regardless
of the characteristics of the original noxa (Tidball, 2002).
Arnold et al. (2007) identiﬁed a population of circulating
monocytes selectively recruited in damaged muscle where they
acquire a anti-inﬂammatory phenotype, correlated to tissue heal-
ing. Which are the signals involved in the functional polarization
of macrophages in the injured/regenerating muscles? The phago-
cytosis of muscle cells debris is most likely to favor this transition
(Arnold et al., 2007).
A macrophage population associated to the epimysial and per-
imysial connective tissue plays a crucial non-redundant role in
monocyte attraction and activation in acutely injured skeletal
muscle, providing signals that control their switch to tissue heal-
ing macrophages (Brigitte et al., 2010). Resident macrophages
also attract in the injured skeletal muscle cells that express the
CD11c integrin, a bona ﬁde marker of myeloid DCs. These cells
are endowed with antigen presenting capacity and with the ability
to migrate from the muscle into draining lymph nodes (Brigitte
et al., 2010). They represent attractive candidates to link the
response to injury in the tissue to the local activation and recruit-
ment of T lymphocytes, a hallmark of persistent skeletal muscle
inﬂammation.
Activated myogenic precursors also generate chemoattractive
signals for inﬂammatory cells, and their ability to recruit them
at the site of muscle injury is further upregulated by the inter-
action with macrophages (Chazaud et al., 2003). After injury,
myogenic precursors, injured ﬁbers, resident macrophages, and
recruited monocytes are a source of CCL2/MCP1 (Chazaud et al.,
2003; Brigitte et al., 2010; Lu et al., 2011a). Indeed, severe impair-
ments in skeletal muscle regeneration occur in mice defective of
the chemokine-CC-motif receptor 2-deﬁcient (CCR2−/−), which
is activatedbyCCL2/MCP1 (Warren et al., 2005).CCR2expression
on bone marrow derived cells is essential for robust macrophage
recruitment after acute sterile injury andmuscle regeneration. Sur-
prisingly, injured muscle of lethally irradiated mice transplanted
with CCR2-deﬁcient bone marrow cells contain, despite impaired
muscle regeneration, increased numbers of myogenic progenitor
cells (Sun et al., 2009), suggesting that macrophages are required
for precursor cells to fuse and yield effective myoﬁber formation.
Drastic reduction of macrophage recruitment in injured muscle
of CCR2−/− mice associates to a dramatically reduced expression
of insulin like growth factor 1 (IGF1), a central regulator of mus-
cle regeneration (Lu et al., 2011b). This observation suggests that
macrophages regulate muscle healing through IGF1. Indeed, in
CCR2−/− mice, local IGF1 injection at least partially makes up for
the lack of recruited macrophages (Lu et al., 2011b).
In vitro, IGF1 elicits in muscle cells a biphasic response, ﬁrst
stimulating cell proliferation and subsequently enhancing myo-
genic differentiation (Rosenthal and Cheng, 1995), a sequence of
events that could be teleologically suited to sustain the repair of
damaged tissue. In vivo, expression of a muscle speciﬁc transgene
encoding a locally acting isoform of IGF1 prompts hypertrophy
and regeneration in senescent skeletalmuscle (Musaro et al., 2001).
THE MUSCLE MICROENVIRONMENT AND THE
INFLAMMATORY RESPONSE
The muscle environment and the mechanisms through which
it modulates regeneration have attracted much attention in the
recent years (Paylor et al., 2011). Several studies have investigated
in particular whether similar events occur during the regenera-
tion of adult skeletal muscle and during embryogenesis (Charge
and Rudnicki, 2004). The microenvironment in which the two
events occur is strikingly diverse: speciﬁcally muscle development
occurs without any substantial contribution by inﬁltrating cells,
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which are instead present in regeneratingmuscle at concentrations
that exceed 100,000 inﬂammatory cells/mm3 of tissue (Wehling
et al., 2001; Paylor et al., 2011). Recent evidences suggest that
a model in which myogenesis occurs independently of the acti-
vation of inﬂammatory pathway may be far too simplistic: for
example,myoblasts of mouse embryos and regenerating myocytes
in injured adult mouse skeletal muscle, but not mature myocytes,
express the receptor for granulocyte colony stimulating factor (G-
CSF). Moreover, the C-CSF/G-CSF receptor pathway is crucial for
skeletalmyocyte development and regeneration (Hara et al., 2011).
Although several molecules have been identiﬁed not to be
dispensable for muscle regeneration, the overall array of signals
macrophages deliver in the tissue and the hierarchy among them
is far from being elucidated. At early stages after acute injury
macrophages mostly secrete inﬂammatory molecules, including
CCL2/MCP1 and TNFα, which may favor tissue wasting via acti-
vation of the FoxO transcription factor (Sandri et al., 2004; Zhao
et al., 2007). Simultaneously, they dispose of apoptotic cells and
ﬁber remnants: apoptotic cell clearance has been shown in other
systems to trigger the release of cytokines involved in the termi-
nation of the inﬂammatory response and in immune regulation,
such as TGFβ and IL10 (Huynh et al., 2002; Zhang et al., 2011; see
also below).
At later stages macrophages actively sustain ﬁber reconstitution
(Summan et al., 2006; Arnold et al., 2007; Shireman et al., 2007).
At this stage they mainly secrete cytokines that may play a trophic
function, such as IGF1 (Musaro et al., 2001; Summan et al., 2006;
Pelosi et al., 2007) or IL10 (Strle et al., 2007, 2008; Tidball and
Villalta, 2010).
In mdx mice, a well-accepted model for human Duchenne’s
muscular dystrophy, the expression of IL10 modulates
macrophage activation and reduces the membrane damage: in
this system, IL10 has been proposed to deactivate the inﬂamma-
tory proﬁle of macrophages inﬁltrating damaged muscle at the
early, acute stage of muscle disease, promoting a switch toward an
alternative activation proﬁle (Villalta et al., 2010). At later phases
however the persistence of alternatively activated macrophages in
conditions in which the tissue can not heal may actually play a
deleterious role: for example the sustained production in mdx
mice of TGFβ may be involved in the ﬁbrotic substitution of the
myoﬁbers, a hallmark of the advanced phases of muscular dys-
trophy: the cytokine indeed is associated to ﬁbroblast activation
and proliferation, leading to sustained collagen production and
eventually to ﬁbrosis (Vidal et al., 2008).
An exclusive population of progenitors of both ﬁbroblasts
and adipocytes has been recently clearly identiﬁed in skeletal
muscle (Joe et al., 2010; Uezumi et al., 2010), referred to as
ﬁbro/adipogenic progenitors (FAP). These cells remain in a quies-
cent state in normal conditions, undergo a dramatic but transient
proliferation in response to injury, contextually delivering trophic
signals for proliferating myogenic precursors. Fibrotic scar substi-
tution and accumulation of lipid ﬁlled adipocytes is a feature of
conditions of the failed regeneration of the skeletal muscle, like
it occurs dramatically in muscle dystrophies but at some extent
also during physiological aging: when myogenic precursors fail to
replace the damaged tissue, FAP would according to recent models
(Rodeheffer, 2010; Paylor et al., 2011) take over,differentiating into
adipocytes and possibly ﬁbroblasts, thus ensuring the structural
continuity of the tissue.
Various stem cell populations, including mesenchymal stem
cells (MSC) and neural precursor cells (NPC), regulate the
leukocyte fate, through mechanisms involving cell–cell contact
and/or various soluble factor. MSC inhibit proliferation of various
immune cells, including T, B, and NK lymphocytes (Groh et al.,
2005; Krampera et al., 2006; Sotiropoulou et al., 2006; Spaggiari
et al., 2006) and speciﬁcally inﬂuence affect DCs function through
the release of IL6, (Djouad et al., 2007), of theNotch ligand Jagged-
2, which induces the generation of regulatory DCs (Zhang et al.,
2009a) and of prostaglandin E2 (Spaggiari et al., 2009), while NPC
restrict the activation of DCs via a BMP-4-dependent-mechanism
(Pluchino et al., 2009). MSC also reprogramming macrophages
toward an alternatively activated proﬁle (Ohtaki et al., 2008; Kim
and Hematti, 2009), which is instrumental in a model of skin
wound healing for effective wound repair (Zhang et al., 2010b).
The possible cross-talk between FAPs and other precursors of
mesenchymal origin and inﬂammatory cells inﬁltrating injured
skeletal muscle, although demonstrated in other model tissues
(Stappenbeck and Miyoshi, 2009; Zhang et al., 2010b; Ehninger
and Trumpp, 2011), has not to the best of our knowledge been
directly investigated so far.
MACROPHAGES AND MYOGENIC PRECURSORS
In the absence of macrophages injured muscle fail to regenerate
(Figure 1; see also above), even if the number and function of the
cell populations with myogenic potential in the tissue, the eventual
effectors of muscle healing that repair or replace injured or dead
ﬁbers (Mauro, 1961), are not directly affected. The results indicate
that macrophages actively “license” myogenic precursors to carry
out their program, i.e., to proliferate, differentiate, and fuse and
thus to regenerate the tissue. This is not an isolated feature of the
skeletalmuscle:macrophages for example sustain the stem cell sur-
vival in various tissues, including the skin and the bone marrow, a
limiting step for their regeneration (Tothova and Gilliland, 2007;
Blanpain and Fuchs, 2009; Discher et al., 2009; Gurumurthy et al.,
2010).
It is still not clear atwhich level(s)macrophages actually speciﬁ-
cally act. For example,myogenic progenitor cells were signiﬁcantly
increased in injured muscle of mice with CCR2-defective bone
marrow cells even if muscle regeneration is severely affected (Sun
et al., 2009). Satellite cells are considered the resident “stem-like”
cells in skeletal muscle and are responsible for muscle growth and
regeneration in postnatal life (Holterman and Rudnicki, 2005).
In response to muscle injuries, quiescent satellite cells undergo
activation, proliferate, and fuse with each other or with damaged
ﬁbers (Kuang et al., 2008); conversely, some precursors undergo
self-renewal, and thusmaintain the integrity of the quiescent satel-
lite cell pool (Zammit, 2008; Kang and Krauss, 2010). A pathway
strictly associated to the control of neoangiogenesis, which com-
prises the interaction between angiopoietin 1 (Ang1) and its recep-
tor Tie-2 and the downstream activation of the ERK1/2 kinase, has
been in elegant studies implicated in the ability of satellite cells to
re-enter the stem cell niche (Abou-Khalil et al., 2009; Mounier
et al., 2011), thus suggesting that endothelial cells and possibly
other non-muscle cells, are involved in the maintenance of the
www.frontiersin.org November 2011 | Volume 2 | Article 62 | 5
Bosurgi et al. Macrophages and skeletal muscle regeneration
satellite cell niche. The observation that even single transplanted
satellite cells both differentiate and self-renew after transplanta-
tion in vivo (Sacco et al., 2008) provides a formal demonstration
that satellite cells are indeed endowed with stem cell properties.
Telomeres length in muscle cells and the control of muscle stem
cell regenerative capacity represents, in particular in the setting of
muscular dystrophies, a particular attractive target for the action
of inﬂammatory molecules (Sacco et al., 2010).
Despite the concentrated effort of several groups, our actual
insight on the role of the microenvironment in determining the
overall outcomeof the tissue response to injury is still fragmentary.
Recent studies speciﬁcally highlight the importance of mechani-
cal factors, such as tissue rigidity/elasticity in regulating the fate
of muscle stem cells (Gilbert et al., 2010), revealing important
caveats that apply to the in vitro systems that are commonly used.
Other environmental inﬂuences are possibly as relevant: for exam-
ple, we have recently observed that regeneration after an acute
sterile injury of the skeletal muscle is accompanied by the substan-
tial generation of ROS production, which is counterbalanced and
rapidly overcome by the generation of antioxidant moieties. Mito-
chondria are initially responsible for ROS formation while at later
time points, non-mitochondrial sources are involved. Both regen-
erating ﬁbers and macrophages express high levels of free thiols
and antioxidant enzymes, such as superoxide dismutase 1 (SOD1)
and thioredoxin (Vezzoli et al., 2011). The well-characterized
role of a reduced environment in maintaining the extracellular
function of DAMP molecules (Lotze et al., 2007; Rubartelli and
Lotze, 2007; Carta et al., 2009; Rubartelli and Sitia, 2009), either
directly released by damaged ﬁbers of actively secreted by inﬁltrat-
ing macrophages suggests that the antioxidant response directly
contributes in the acutely injured tissue to homeostasis.
Preliminary data from our laboratory indicate that
macrophages also inﬂuence other cells with myogenic potential,
such as mesoangioblasts. Mesoangioblasts are vessel-associated
progenitors that ameliorate defective muscle structure and func-
tion in dystrophic mice and dogs (Sampaolesi et al., 2003, 2006;
Tedesco et al., 2010). A clonal analysis of embryonic explanted
organ rudiments led to the positive identiﬁcation of a “mesoan-
gioblast”cell population in the embryonic dorsal aorta (DeAngelis
et al., 1999) and later studies implicated pericytes associated with
microvascular walls in the human skeletal muscle as their human
counterpart (Dellavalle et al., 2007). Mesoangioblasts are endowed
with the ability to cross the vessel wall, a feature missing in
satellite cell-derived myogenic precursors (Dellavalle et al., 2007):
when injected into the blood, mesoangioblasts are indeed able to
migrate outside the vessel toward injured and inﬂamed tissues,
including the dystrophic muscle (Sampaolesi et al., 2003), possi-
bly following chemotactic signals generated by activated innate
cells, macrophages in particular (Lolmede et al., 2009). These
features allow a systemic delivery of mesoangioblasts, thus over-
coming migration-related problems described for other stem cell
populations. In the recent years various tools were investigated to
improve mesoangioblast migration toward damaged muscle and
their local differentiation to optimize future cell therapy protocols
for muscular dystrophies (Tedesco et al., 2010).
Macrophages are important to recruit and locally activate
mesoangioblasts, committing them to myogenic differentiation.
Conversely, we have observed that mesoangioblasts regulate gene
expression of in vitro bone marrow derived macrophages (Bosurgi
et al., unpublished results). Genes associated to macrophage
scavenger function, phagocytic activity, chemokines release, and
response to cytokines, which are regulated at the expression
level, are all targets of mesoangioblast action. Their regulation
is selective, since several other genes associated to macrophage
housekeeping functions, to the iron metabolism and to the redox
control are unaffected. We are actively verifying the possibility
that mesoangioblasts prime the macrophages function toward a
regulatory activity and this ﬁnely tuned cross-talk regulates the
outcome of tissue remodeling.
CONCLUSION
In summary, myogenic precursors derived from satellite cells and
other muscle stem cells are the ﬁnal effectors of muscle regen-
eration. Substantial evidence indicates that they need licensing
by accessory cells, in particular by inﬂammatory cells such as
macrophages. Other mesenchymal precursors expand when mus-
cle regeneration fails, leading to the eventual ﬁbrotic scar and
fat replacement of the tissue. The latter event is again possibly
dependent on the inﬂammatory environment of the tissue. The
efforts of the next years are likely to break the code by which the
immune response controls the regeneration of the skeletal muscle,
thus leading to the development of effective targeted therapies for
genetic defects of the tissue and for the most common causes of
physiological muscle wasting and sarcopenia.
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